Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Alimera Sciences, Inc. (ALIM)

« Back to company index

ALIM Chatter Timeline

Stock Ticker for ALIM

Most Active Tweeters for ALIM

UserTweets
@arhamgrowthcap 2
@COCKRELLGROUP 1
@ez_alertz 1
@StockNewsNow 1
@filingsdb 1

Recent Tweets for ALIM

newswithvalue @newswithvalue
$ALIM: What Type Of Shareholder Owns Alimera Sciences, Inc.’s (NASDAQ …: https://t.co/G7GRnvqPkX
June 12th 2019, 3:06pm
Swan827 @Swan827
RT @arhamgrowthcap: Gave a shot at modeling $ALIM and I still need to see the comparable data but I can already make the case it's at least…
June 10th 2019, 4:06pm
arhamgrowthcap @arhamgrowthcap
Gave a shot at modeling $ALIM and I still need to see the comparable data but I can already make the case it's at least 50-75% undervalued
June 10th 2019, 4:06pm
arhamgrowthcap @arhamgrowthcap
I'm very interested in growing my $ALIM position. Great company and the stock has literally everything I look for.… https://t.co/qZeo11Kxi1
June 8th 2019, 6:06pm
MaisaCorp @MaisaCorp
$ALIM plans to start selling its Iluvien treatment for non-infectious uveitis, a swelling of the eye, in Europe in H2 2019.
June 6th 2019, 1:06pm
StockNewsNow @StockNewsNow
$ALIM Three-Year Clinical Trial Results Support ILUVIEN® Launch in Europe for the Prevention of Relapse in Recurren… https://t.co/Xwd2SXLK7H
June 6th 2019, 10:06am
COCKRELLGROUP @COCKRELLGROUP
Alimera $ALIM announce: 3 Yr Clinical Trial Results Support ILUVIEN® Launch in Europe for Prevention of Relapse in… https://t.co/vW6LgSXPEt
June 6th 2019, 9:06am
Allstocknews @Allstocknews
$ALIM Three-Year Clinical Trial Results Support ILUVIEN® Launch in Europe for the Prevention of Relapse in Re From our Stock News Alerts App
June 6th 2019, 8:06am
marketexclusive @marketexclusive
$ALIM ALIMERA SCIENCES, INC. (NASDAQ:ALIM) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued List… https://t.co/4ZvOGmsi3R
June 5th 2019, 6:06am
Stock_News_Now @Stock_News_Now
$ALIM: New SEC Filing for ALIM: Form 8-K (No. 0001267602-19-000079): https://t.co/M67TPFHokM
June 4th 2019, 5:06pm
StockTexts @StockTexts
$ALIM Alimera Sciences, Inc. SEC Filing: Form 8-K https://t.co/WMTio3A87n
June 4th 2019, 5:06pm
filingsdb @filingsdb
New Form 8-K filed by ALIMERA SCIENCES INC $ALIM - https://t.co/edSO2U6Z9Q
June 4th 2019, 5:06pm
ez_alertz @ez_alertz
$ALIM Alimera Sciences Sees Hammer Chart Pattern: Time to Buy? https://t.co/NBkLQHHKKB
June 4th 2019, 6:06am
TickerReport @TickerReport
Alimera Sciences Inc $ALIM Given Average Rating of “Buy” by Analysts https://t.co/C7PYqozJIQ
June 3rd 2019, 9:06pm
bbnsnews @bbnsnews
Brokerages Anticipate Alimera Sciences Inc $ALIM Will Post Quarterly Sales of $12.97 Million https://t.co/0rQkFxYWsT
June 3rd 2019, 9:06pm
arhamgrowthcap @arhamgrowthcap
@100BaggerHunter Thomas, $ALIM expects to be profitable at a level of $13.5M in sales for a quarter. Last quarter t… https://t.co/dxxqiZVEwb
June 3rd 2019, 5:06pm
EnterpriseLeade @EnterpriseLeade
Head to Head Analysis: Alimera Sciences $ALIM vs. Mallinckrodt $MNK https://t.co/TJb5uT2kAW
June 3rd 2019, 2:06am
registrarjourn @registrarjourn
Head to Head Analysis: Alimera Sciences $ALIM vs. Mallinckrodt $MNK https://t.co/WnCr9eUeFA
June 3rd 2019, 2:06am
OlympiaReport @OlympiaReport
Alimera Sciences $ALIM Now Covered by Analysts at Craig Hallum https://t.co/r6CZmOiZCz
June 1st 2019, 5:06am
ThisLincolnian @ThisLincolnian
Alimera Sciences $ALIM Now Covered by Analysts at Craig Hallum https://t.co/3A3B2WtvPx
June 1st 2019, 5:06am
WeekHerald @WeekHerald
Alimera Sciences $ALIM Now Covered by Analysts at Craig Hallum https://t.co/PPiJ4MMeb1
June 1st 2019, 5:06am
ConsumerFeed @ConsumerFeed
-$0.04 EPS Expected for Alimera Sciences Inc $ALIM This Quarter https://t.co/hj8izsdXon
May 30th 2019, 9:05am
AmericanBanking @AmericanBanking
Contrasting Mallinckrodt $MNK & Alimera Sciences $ALIM https://t.co/p2YRGlGB7P #stocks
May 29th 2019, 4:05pm
arhamgrowthcap @arhamgrowthcap
$ALIM met with management last week at B. Riley. Great healthcare company no more testing nor approval required. Ba… https://t.co/86qnCbA3tC
May 29th 2019, 7:05am
AmericanBanking @AmericanBanking
$12.97 Million in Sales Expected for Alimera Sciences Inc $ALIM This Quarter https://t.co/PWttTEeiaY #stocks
May 29th 2019, 3:05am
ConsumerFeed @ConsumerFeed
Craig Hallum Begins Coverage on Alimera Sciences $ALIM https://t.co/1Bs6ZUn0eQ
May 29th 2019, 3:05am
AmericanBanking @AmericanBanking
Alimera Sciences $ALIM Now Covered by Analysts at Craig Hallum https://t.co/xxrXPGch6s #stocks
May 28th 2019, 8:05am
firsttomarkets @firsttomarkets
Alimera Sciences Inc Initiated Coverage by Craig-Hallum (Ranked 52nd) to Buy $ALIM #ALIM https://t.co/sutdsaDAHl
May 28th 2019, 8:05am
Briefingcom @Briefingcom
$ALIM: Craig Hallum starts at Buy
May 28th 2019, 7:05am
dailypoliticaln @dailypoliticaln
Zacks: Analysts Expect Alimera Sciences Inc $ALIM Will Post Earnings of -$0.04 Per Share https://t.co/bXxpEGfbew
May 27th 2019, 10:05am
AmericanBanking @AmericanBanking
Alimera Sciences Inc $ALIM Expected to Announce Earnings of -$0.04 Per Share https://t.co/2vDgyoCbuH #stocks
May 27th 2019, 10:05am
AmericanBanking @AmericanBanking
Alimera Sciences Inc $ALIM Receives Average Recommendation of “Buy” from Brokerages https://t.co/YAzJjt2kg9 #stocks
May 27th 2019, 8:05am
betrbiz @betrbiz
RT @Allstocknews: $ALIM Alimera Sciences Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and Educat From our St…
May 22nd 2019, 1:05pm
StockNewsNow @StockNewsNow
$ALIM Alimera Sciences Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and Educate Cons… https://t.co/S9S7y0BwUZ
May 22nd 2019, 10:05am
COCKRELLGROUP @COCKRELLGROUP
$ALIM Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and Educate Consumers on Diabetic… https://t.co/SOsf45jzU2
May 22nd 2019, 9:05am
VisualStockRSRC @VisualStockRSRC
$ALIM - Alimera Sciences Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and https://t.co/FoWbMg2BNf
May 22nd 2019, 8:05am
Allstocknews @Allstocknews
$ALIM Alimera Sciences Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and Educat From our Stock News Alerts App
May 22nd 2019, 8:05am
SwingTradeBot @SwingTradeBot
20 DMA Support today: $ALIM ... https://t.co/deOpbNqdR6
May 21st 2019, 12:05pm
ez_alertz @ez_alertz
$ALIM Top Ranked Momentum Stocks to Buy for May 21st https://t.co/8fGfsaQMrz
May 21st 2019, 10:05am
HottestStockNow @HottestStockNow
$ALIM to Present a Corporate Overview at Upcoming Investor Conference https://t.co/qkHEedX03S
May 15th 2019, 7:05am
StockNewsNow @StockNewsNow
$ALIM Alimera Sciences to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019 https://t.co/IqlolEpFv0
May 14th 2019, 10:05am
COCKRELLGROUP @COCKRELLGROUP
Alimera Sciences $ALIM Present at 20th Annual B. Riley FBR Inst. Investor Conf. May 22 President & CEO, Rick Eiswir… https://t.co/VXqUcolr3l
May 14th 2019, 9:05am
ez_alertz @ez_alertz
$ALIM Alimera Sciences to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019 https://t.co/B7uWpv2DmU
May 14th 2019, 8:05am
Allstocknews @Allstocknews
$ALIM Alimera Sciences to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22 From our Stock News Alerts App
May 14th 2019, 8:05am
dispatchtribune @dispatchtribune
$12.25 Million in Sales Expected for Alimera Sciences Inc $ALIM This Quarter https://t.co/pkektzOWvj
May 11th 2019, 7:05pm
registrarjourn @registrarjourn
Zacks: Analysts Expect Alimera Sciences Inc $ALIM Will Post Earnings of -$0.06 Per Share https://t.co/lfm8dxYv1F
May 11th 2019, 7:05pm
EnterpriseLeade @EnterpriseLeade
Zacks: Analysts Expect Alimera Sciences Inc $ALIM Will Post Earnings of -$0.06 Per Share https://t.co/sZcywWIwGM
May 11th 2019, 7:05pm
ThisLincolnian @ThisLincolnian
Analysts Set Alimera Sciences Inc $ALIM Price Target at $2.92 https://t.co/ilQf2h5QoD
May 9th 2019, 10:05pm
dailypoliticaln @dailypoliticaln
$12.25 Million in Sales Expected for Alimera Sciences Inc $ALIM This Quarter https://t.co/disk1I3xwu
May 9th 2019, 3:05pm
TickerReport @TickerReport
-$0.06 EPS Expected for Alimera Sciences Inc $ALIM This Quarter https://t.co/BU2YAEnE0m
May 9th 2019, 3:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.